Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |